ロード中...
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers.
1 The new converting enzyme inhibitor RHC 3659 was tested in 15 male volunteers. The study consisted of two parts: first, the ability of a single oral dose (5, 10, 20, 40 or 80 mg) to inhibit the pressor response to exogenous angiotensin I was tested with blood pressure and heart rate monitored cont...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1981
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1401926/ https://ncbi.nlm.nih.gov/pubmed/6280740 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|